Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

A patient developed a severe skin reaction and died after taking hydroxychloroquine for COVID-19.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

Some COVID-19 pneumonia patients in Veracruz, Mexico, had skin issues, with reversible hair loss linked to disease severity.

People living with HIV in Turkey often have skin conditions, which are more common in advanced HIV stages and may help in diagnosing the infection.

Long-term use of Risperidone may be linked to a serious skin condition in bipolar patients, affecting their overall well-being.

Dermoscopy can help diagnose secondary syphilis by distinguishing it from other skin issues.

Early diagnosis, innovative treatments, and considering systemic conditions are crucial in dermatological care.

COVID-19 may trigger systemic lupus erythematosus, requiring careful diagnosis and treatment.

Nail changes from immunotherapy can be managed without stopping cancer treatment.

An 80-year-old man grew extra hair on his forearms after starting Alzheimer's medication rivastigmine.

Demodex mites are common in adults and elderly, emerging in children, and require careful diagnosis and treatment.

Secondary syphilis in Cali, Colombia, shows high Treponema pallidum presence and challenges in early diagnosis, needing better public health strategies.

Chemotherapy for prostate, bladder, and testicular cancer patients commonly causes hair loss, fatigue, and decreased appetite.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

The document suggests there might be a link between Kawasaki Disease and Alopecia Areata that needs more research.

Hair loss in a drug reaction case involved both a common shedding phase and an immune attack on hair follicle stem cells.

DCP therapy causes side effects like weakness, flushing, headaches, and taste changes, but less frequently causes hypertension and diabetes.

An adult with Kawasaki disease experienced temporary heart failure but recovered without lasting heart damage.

A COVID-19 patient had unusual nail discoloration and nail separation possibly due to the virus's effects on small blood vessels.

The medication lopinavir-ritonavir may cause severe hair loss.

Malarone® caused pancreatitis and hair loss in a dog for the first time.

The conclusion of the case is not provided in the summary.

Toxic Shock Syndrome mainly affects menstruating women, can recur, and is linked to staph bacteria, with rapid treatment being crucial.

Shen-Min, a hair growth supplement, likely caused acute hepatitis in a woman, improving after she stopped taking it.

Dermatologists play a key role in identifying and documenting signs of abuse and injury for forensic investigations.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Rivaroxaban can cause liver injury, allergic reactions, blood vessel inflammation, and hair loss, but these side effects are rare.

The document concludes that parathyroid diseases have a range of clinical features and outcomes, with some conditions being treatable and others having a high risk of mortality.